Consort Medical plc (CSRT.L) (LON:CSRT) Shares Pass Above 200-Day Moving Average – Time to Sell?
by Michael Walen · The Markets DailyConsort Medical plc (CSRT.L) (LON:CSRT – Get Free Report)’s stock price crossed above its 200-day moving average during trading on Thursday . The stock has a 200-day moving average of GBX 1,010 ($13.15) and traded as high as GBX 1,010 ($13.15). Consort Medical plc (CSRT.L) shares last traded at GBX 1,010 ($13.15), with a volume of 768 shares.
Consort Medical plc (CSRT.L) Price Performance
The company has a debt-to-equity ratio of 55.58, a current ratio of 1.83 and a quick ratio of 1.16. The firm has a market capitalization of £504.60 million and a price-to-earnings ratio of 127.85. The stock has a 50 day moving average price of GBX 1,010 and a two-hundred day moving average price of GBX 1,010.
Consort Medical plc (CSRT.L) Company Profile
Consort Medical plc operates as a one-stop developer and manufacturer of drugs and premium drug delivery devices. It operates through two divisions, Bespak and Aesica. The company provides various life improving treatments to patients across worldwide through the design, development, and manufacture of medical devices for inhaled, injectable, nasal, and ocular drug delivery, as well as point of care diagnostics products.
Featured Articles
- Five stocks we like better than Consort Medical plc (CSRT.L)
- How to Invest in Blue Chip Stocks
- Airbnb Stock Attracts Attention With Strong Cash Flow Strategy
- There Are Different Types of Stock To Invest In
- MarketBeat Week in Review – 11/4 – 11/8
- Most Volatile Stocks, What Investors Need to Know
- Trump’s Return: Which Sectors Will Benefit Most?